Amporin Pharmaceuticals
Amporin Home
Amporin Pharmaceuticals was founded in 2024 and is headquartered in Basel, Switzerland.
- Headquarters
- Basel
- Founded
- 2024
- Business Model
- B2B
- Website
- amporin.com
About
Amporin Pharmaceuticals develops oral small-molecule drugs that target toxic membrane pores formed by misfolded protein oligomers. Its approach seeks to protect and repair cellular membranes, rescue mitochondria, and restore cellular function in degenerative diseases associated with protein misfolding and aggregation. The company’s lead program focuses on Parkinson’s disease, with additional programs in Alzheimer’s disease and Type 2 diabetes.
Summary
Amporin Pharmaceuticals is a Biotech company based in Basel, Switzerland, founded in 2024.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amporin-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/amporin-pharmaceuticals" alt="Amporin Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>